quinoxalines has been researched along with Carcinoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Obaidy, KI; Cheng, L | 1 |
| Chen, J; Chen, L; Li, W; Liang, G; Shu, Y; Wang, J; Wu, H; Wu, J; Yao, S; Zhang, L; Zhu, M | 1 |
| Bulusu, G; Bung, N; Ghosh, A; Haldar, D; Nakhi, A; Pal, M; Seerapu, GPK; Sengupta, A; Shivaji Ramarao, EVV | 1 |
| Cao, L; Cao, Y; Huang, BJ; Lin, ZR; Meng, DF; Peng, LX; Qian, CN; Sun, R; Wang, MY; Xie, P; Xu, L; Yang, JP; Zheng, LS | 1 |
| Katiyar, SK; Punathil, T; Tollefsbol, TO | 1 |
| El-Khatib, M; Gali-Muhtasib, H; Geara, F; Haddadin, MJ | 1 |
| Barnett, SF; Defeo-Jones, D; Fu, S; Hancock, PJ; Haskell, KM; Huber, HE; Jones, RE; Kahana, JA; Kral, AM; Leander, K; Lee, LL; Malinowski, J; McAvoy, EM; Nahas, DD; Robinson, RG | 1 |
| Bieberschulte, W; Gille, L; Jurek, D; Marian, B; Nohl, H; Rohr-Udilova, N; Schulte-Hermann, R | 1 |
| Futakuchi, M; Hirose, M; Kimoto, N; Kono, T; Lin, C; Nishibe, S; Shirai, T; Yamaguchi, T | 1 |
| Adelson, MD; Baker, VV; Barnhill, DR; Blessing, JA; Muss, HB | 1 |
| Baker, LH; Decker, D; Haas, CD; Leichman, CG; Pazdur, R | 1 |
| Hasegawa, H; Kato, T; Ohgaki, H; Sato, S; Suenaga, M; Sugimura, T; Takayama, S | 1 |
| Bucchini, D; Fiszman, M; Girard, M | 1 |
| Artico, M; Chimenti, F; Dolfini, E; Giuliano, R; Morasca, L; Vomero, S | 1 |
1 review(s) available for quinoxalines and Carcinoma
| Article | Year |
|---|---|
Fibroblast growth factor receptor (
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Exons; Gene Amplification; Gene Fusion; Genetic Predisposition to Disease; Humans; Molecular Targeted Therapy; Mutation, Missense; Phenotype; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 3; Thiophenes; Urinary Bladder Neoplasms; Urothelium | 2021 |
1 trial(s) available for quinoxalines and Carcinoma
| Article | Year |
|---|---|
Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Carcinoma; Drug Evaluation; Echinomycin; Female; Humans; Infusions, Intravenous; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Ovarian Neoplasms; Quinoxalines; Remission Induction | 1990 |
12 other study(ies) available for quinoxalines and Carcinoma
| Article | Year |
|---|---|
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Curcumin; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Laryngeal Neoplasms; NF-kappa B; Quinoxalines; Tumor Necrosis Factor-alpha | 2017 |
A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HCT116 Cells; Humans; Molecular Structure; Quinoxalines; Sirtuin 1; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2017 |
PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.
Topics: Adult; Aged; Animals; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Female; Gene Expression Profiling; Humans; Indolizines; Kaplan-Meier Estimate; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quinoxalines; Reactive Oxygen Species; Signal Transduction; Theranostic Nanomedicine; Transcriptome; Xenograft Model Antitumor Assays | 2016 |
EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase.
Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Mammary Neoplasms, Animal; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Oxides; Oxadiazoles; Quinoxalines | 2008 |
Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
Topics: Antineoplastic Agents; Carcinoma; Cell Death; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Quinoxalines; Tumor Suppressor Protein p53 | 2010 |
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adenosine Triphosphate; Apoptosis Regulatory Proteins; Benzylamines; Binding, Competitive; Blood Proteins; Carcinoma; Caspases; Cell Line, Tumor; Cloning, Molecular; Enzyme Activation; Enzyme Inhibitors; Female; Heterocyclic Compounds, 2-Ring; Humans; Isoenzymes; Male; Membrane Glycoproteins; Molecular Structure; Peptides; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinoxalines; Sequence Homology, Amino Acid; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2005 |
Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour- promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat.
Topics: Adenoma; Carcinoma; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dietary Fats; Gene Expression Regulation, Neoplastic; Humans; Linoleic Acids; Lipid Peroxides; Organic Chemicals; Pyrazoles; Quinoxalines; Sulfonamides; Tumor Cells, Cultured; Ubiquinone; Vascular Endothelial Growth Factor A | 2005 |
Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats.
Topics: Animals; Biological Assay; Body Weight; Carcinogens; Carcinoma; Colonic Neoplasms; Diet; Drugs, Chinese Herbal; Female; Fibroadenoma; Furans; Glucosides; Glutathione Transferase; Imidazoles; Liver; Male; Mammary Neoplasms, Experimental; Pancreatic Neoplasms; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Time Factors | 2000 |
Phase I study of echinomycin.
Topics: Carcinoma; Echinomycin; Humans; Intercalating Agents; Quinoxalines | 1987 |
Carcinogenicities in mice and rats of IQ, MeIQ, and MeIQx.
Topics: Adenocarcinoma; Adenoma; Animals; Carcinoma; Carcinoma, Squamous Cell; Female; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Quinolines; Quinoxalines; Rats; Rats, Inbred F344; Stomach Neoplasms | 1985 |
On a new inhibition of poliovirus RNA replication.
Topics: Antiviral Agents; Carcinoma; Cell Line; Isoleucine; Leucine; Mouth Neoplasms; Poliovirus; Quinoxalines; RNA, Viral; Time Factors; Tritium; Uridine; Viral Proteins; Virus Replication | 1974 |
[Research on antineoplastic substances. LI. Derivatives of benzo(f)-pyrrolo-(1,2-a)-quinoxaline and naphtho-(2,1-e)-pyrrolo-(2,1-c)-as-triazine: synthesis and cytostatic and cytotoxic activity].
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line; Cells, Cultured; Culture Media; Humans; Mouth Neoplasms; Nasopharyngeal Neoplasms; Pyrroles; Quinoxalines; Structure-Activity Relationship; Triazines | 1973 |